Moses Makunje

Comptroller/Controller/Revisor på NUVATION BIO INC.

Förmögenhet: 325 695 $ per 2026-05-31

48 år

Health Technology

Consumer Services

Profil

Moses Makunje is currently VP-Finance & Principal Accounting Officer at Nuvation Bio, Inc. since 2020.
Formerly, Mr. Makunje was Controller at Adverum Biotechnologies, Inc. from 2017 to 2019 and Controller at Maze Therapeutics, Inc. from 2019 to 2020.
Mr. Makunje completed undergraduate and MBA degrees at Golden Gate University.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
NUVATION BIO, INC. CLASS A 0,02 %	2026-02-27	68 137 ( 0,02 % )	325 695 $	2026-05-31

Aktiva positioner av Moses Makunje

Företag	Position	Start
NUVATION BIO INC.	Comptroller/Controller/Revisor	2023-11-27

Alla aktiva positioner av Moses Makunje

Tidigare kända positioner av Moses Makunje

Företag	Position	Slut
Maze Therapeutics, Inc. Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases	Comptroller/Controller/Revisor	2020-07-01
ADVERUM BIOTECHNOLOGIES, INC.	Comptroller/Controller/Revisor	2019-03-01

Se detaljerna i Moses Makunjes erfarenhet

Moses Makunjes utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Moses Makunjes erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Golden Gate University Golden Gate University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Adverum Biotechnologies, Inc. Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies	Health Technology
Maze Therapeutics, Inc. Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases	Health Technology
Nuvation Bio, Inc. Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates	Health Technology